NIH-funded research R01 grant

Understanding how DNA changes in older adults affect their health

Official title: Gene regulatory network modeling of disease-associated DNA methylation perturbations

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11089406 · Data updated 2026-11-12

This study is looking at how certain gene changes related to DNA can affect the health of older adults, especially those over 65, to better understand age-related diseases and improve future treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJune 1, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$762,041
NIH project number5R01AI173314-03
Project IDNIH-11089406 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 65 and older who may have mutations in the DNMT3A or TET2 genes.

Less likely to help

Patients under the age of 65 or those without the specific genetic mutations being studied may not benefit from this research.

What this research studies

This research investigates how specific mutations in genes related to DNA methylation impact the health of older adults, particularly those over 65. By using advanced human stem cell models, the study aims to understand how these mutations can lead to various age-related diseases and increased mortality. The researchers will employ computational modeling to connect changes in DNA methylation to immune system responses, potentially revealing new insights into disease mechanisms. This approach may help identify at-risk individuals and inform future treatments.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of age-related diseases, improving health outcomes for older adults.

How similar studies have gone: Previous research has shown that understanding genetic mutations and their effects on health can lead to significant advancements in treatment and prevention strategies, suggesting this approach has potential for success.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Miraldi, Emily — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Miraldi, Emily

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.